Novolin R

This page contains recent news articles, when available, and an overview of Novolin R but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.


Overview:

Novolin R
(when available)

Pharmacology and use:
Used in the treatment of type I and type II diabetes. The primary activity of insulin is the regulation of glucose metabolism. In muscle and other tissues (except the brain), insulin causes rapid transport of glucose and amino acids intracellularly. It also promotes anabolism, and inhibits protein catabolism. In the liver, insulin promotes the uptake and storage of glucose in the form of glycogen, inhibits gluconeogenesis, and promotes the conversion of excess glucose into fat. For treatment of diabetes (type I and II)

Mechanism Of Action:
Insulin binds to the insulin receptor (IR), a heterotetrameric protein consisting of two extracellular alpha units and two transmembrane beta units. The binding of insulin to the alpha subunit of IR stimulates the tyrosine kinase activity intrinsic to the beta subunit of the receptor. The bound receptor is able to autophosphorylate and phosphorylate numerous intracellular substrates such as insulin receptor substrates (IRS) proteins, Cbl, APS, Shc and Gab 1. These activated proteins, in turn, lead to the activation of downstream signaling molecules including PI3 kinase and Akt. Akt regulates the activity of glucose transporter 4 (GLUT4) and protein kinase C (PKC) which play a critical role in metabolism and catabolism.

News Articles on Insulin recombinant

FDA Approvals: Hyzaar, Levemir, NovoLog/Novolin R  -  Oct 27, 2005
Oct. 27, 2005 -- The US Food and Drug Administration (FDA) has approved a new dose for losartan potassium plus hydrochlorothiazide tablets to facilitate ... Medscape

Intravenous Novolin R.(PRODUCTS)  -  Mar 1, 2006
Novolin R regular, human insulin injection (rDNA origin) is indicated for injection/intravenous administration for the treatment of patients with diabetes ... Free with registration - Internal Medicine News - AccessMyLibrary.com

Intravenous Novolin R.(Products)  -  Apr 1, 2006
Novolin R regular, human insulin injection (rDNA origin) is indicated for injection/intravenous administration for the treatment of patients with diabetes ... Free with registration - Family Practice News - AccessMyLibrary.com

Article: Intravenous Novolin R.(PRODUCTS) - Internal Medicine News | ...  -  Mar 1, 2006
Intravenous Novolin R.(PRODUCTS) ... find Internal Medicine News articles. Novolin R regular, human insulin injection (rDNA origin) is indicated for ... Pay-Per-View - Internal Medicine News - HighBeam Research

Press Release: Study Demonstrates Long-term Efficacy and Safety of …  -  Jan 27, 2005
Study Demonstrates Long-term Efficacy and Safety of NovoLog(R) Mix 70/30 in Type 2 Diabetes as Compared to Biphasic Human Insulin 30. from PR Newswire. Pay-Per-View - PR Newswire - HighBeam Research

Press Release: Study Showed that People with Type 2 Diabetes Treated ...  -  Sep 10, 2008
Study Showed that People with Type 2 Diabetes Treated with Lantus(R) and Apidra(R) Achieved Significant Reductions in A1C When Compared to Those Treated ... Pay-Per-View - PR Newswire - HighBeam Research

Article: Intravenous Novolin R.(Products) - Family Practice News | …  -  Apr 1, 2006
Intravenous Novolin R.(Products) ... find Family Practice News articles. Novolin R regular, human insulin injection (rDNA origin) is indicated for ... Pay-Per-View - Family Practice News - HighBeam Research

Study Demonstrates Long-term Efficacy and Safety of NovoLog(R) Mix...  -  Jan 27, 2005
According to a two-year head-to-head study published today in the European Journal of Internal Medicine, patients with type 2 diabetes showed reduced ... $4.95 - PR Newswire - ECNext

Intravenous Novolin R.(PRODUCTS)  -  Mar 1, 2006
Novolin R regular, human insulin injection (rDNA origin) is indicated for injection/intravenous administration for the treatment of patients with diabetes ... Pay-Per-View - Internal Medicine News - Factiva, from Dow Jones

Intravenous Novolin R.(Products)  -  Apr 1, 2006
Novolin R regular, human insulin injection (rDNA origin) is indicated for injection/intravenous administration for the treatment of patients with diabetes ... Pay-Per-View - Family Practice News - Factiva, from Dow Jones

Article: Insulin injection refresher improves Hb[A.sub.1c] levels.(Met...  -  Aug 1, 2007
Article: Intravenous Novolin R.(Products) Family Practice News; April 1, ... Novolin R regular, human insulin injection (rDNA origin) is indicated for ... Pay-Per-View - Family Practice News - HighBeam Research

Lantus lows  -  Sep 15, 2007
The two previous days I received 8 units premeal of Novolin R with a penfill, in that specific day I didn´t do any special excercice work, ... HealthCentral.com

American ginseng.  -  Aug 1, 2006
What is it? American ginseng is an herbal medicine used to increase physical and mental well being. It may also be used to treat high blood sugar. ... Free with registration - AltCareDex Alternative Medicines - AccessMyLibrary.com

Type 2 Diabetes and Insulin  -  Jan 8, 2008
The oldest type of short-acting insulin is Regular insulin (Humulin R and Novolin R). It lasts about 6–8 hours and has its peak about 2 hours after ... Diabetes Self Management

Learn about Insulin Injection from Consumer Reports Health.  -  Jan 7, 2007
If you are using a regular insulin (Humulin R, Novolin R), the insulin should be as clear, colorless, and fluid as water. Do not use this type of insulin if ... consumerreports.org

Press Release: Pfizer Inc. Review in Progress. - M2 Presswire | …  -  Apr 9, 2008
Diamyd Medical- Eli Lilly- Exubera- Humalog- Humulin R- Lantus ... Nordisk- Novolin R- NovoLog- Pfizer- Prograf- Rapamune- Roche ... ... Pay-Per-View - M2 Presswire - HighBeam Research

Havrix, NovoLog.(New & Approved)  -  Nov 1, 2005
Researchers found 187 patients taking Novolog achieved glycemic control similar to that of 96 patients taking Novolin R. The outcome was measured by ... Free with registration - Pediatric News - AccessMyLibrary.com

Merger and Acquisition Scenario  -  Nov 29, 2008
Novolin 70/30 (Isophane/Regular Insulin); Novolin R (Regular Insulin); Novolin N (Isophane Insulin Suspension). Non-Insulin Dependent Diabetes Mellitus ... $250.00 - Revere Reports - Revere

What I'm Doing About Health Issues  -  Apr 2, 2007
I take Lantus and Novolin R (prn on a sliding scale), Neurontin, and Lisinopril. I take Requip. I have come to this website to find friends and support. ... HealthCentral.com

FDA Approvals: Remicade, Neulasta, NovoLog  -  Sep 22, 2005
...aspart achieved a level of glycemic control (as measured by hemoglobin A1C) comparable to that of the company's regular human insulin (Novolin R). ... Medscape

Kansas Regulations - 129-5-1. Prior authorization.  -  Nov 3, 2005
...and cartridges of insulin: (A) Humalog® (B) Humalog Mix® (C) Humulin R® (D) Humulin N® (E) Humulin 70/30® (F) Novolog® (G) Novolog Mix® (H) Novolin R® ... Pay-Per-View - Kansas Regulations - Loislaw

Free Medicine Foundation Helps Diabetics Receive Prescription …  -  Dec 13, 2006
...and cartridges, Lantus, Metformin, Micronase, Minirin Ddavp, Novolin 70/30, Novolin N, Novolin R, NPH human insulin, NPH insulin and hundreds more. ... prleap.com

INSULIN (Parenteral route).(Drug overview)  -  May 1, 2007
Novolin R * Novolog * Velosulin BR DESCRIPTION OF USE Insulin is one of many hormones that helps the body turn the food we eat into energy. ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com

Merger and Acquisition Scenario  -  Nov 22, 2008
Novolin 70/30 (Isophane/Regular Insulin); Novolin N (Isophane Insulin Suspension); Novolin R (Regular Insulin). Non-Insulin Dependent Diabetes Mellitus ... $250.00 - Revere Reports - Revere

Press Release: First Global Guidelines Endorse metformin ( …  -  Oct 3, 2005
First Global Guidelines Endorse metformin (GLUCOPHAGE(R)) as Foundation of Oral Antidiabetic Therapy. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research

Top 200 drugs used in hospitals in 2006.(Table)  -  Apr 16, 2007
108 Omniscan 79553893.19 9.63 109 CellCept 78831154.82 2.74 110 Decavac 77493843.60 9.23 111 Novolin R 77370463.98 75.22 112 Aloxi 77246091.00 45.93 113 ... $4.95 - Drug Topics - ECNext

Press Release: FDA approves Prograf to prevent rejection of heart …  -  Mar 31, 2006
Exubera- Humalog- Humulin R- Lantus- Neuroendocrine Biosciences- Novartis- Novo Nordisk- Novolin R- NovoLog- Pfizer- Prograf- Rapamune- Roche- ... Pay-Per-View - M2 Presswire - HighBeam Research

Diabetic nephropathy in patients with type 1 diabetes mellitus.(Contin...  -  Jan 1, 2006
A 34-year-old Caucasian male, RW, was seen in the nephrology clinic on the advice and referral of his primary care physician. A recent fasting lipoprotein ... $4.95 - Nephrology Nursing Journal - ECNext

Competitors by Product Report  -  Jul 15, 2006
AERx iDMS/NN 1998 (Aerosolized Insulin); Novolin 70/30 (Isophane/Regular Insulin); Novolin N (Isophane Insulin Suspension); Novolin R (Regular Insulin) ... $75.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Mar 11, 2006
AERx iDMS/NN 1998 (Aerosolized Insulin); Novolin R (Regular Insulin); Novolin N (Isophane Insulin Suspension); Novolin 70/30 (Isophane/Regular Insulin) ... $250.00 - Revere Reports - Revere

Brand Names/Synonyms:
Novolin R is also known by the following brand names and/or synonymsInsulin precursor; Novolin R (Novo Nordisk)

Drug Category:
Novolin R is categorized under the following by the FDA: Hypoglycemic Agents; insulins (68:20.08)

Dosage Forms:
LIQUID

Absorption:
Not Available

Interactions:
Not Available



Chemical IUPAC Name:
Human insulin





Health Home | Conditions | Cancer | Medications | Surgery | Vaccines


The Cancer News Network


Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on cancernewsnetwork.org lead to other sites. cancernewsnetwork.org does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is CancerNewsNetwork.org responsible for dead or misdirected links.

IF YOU NEED A LINK OR TEXT REMOVED FROM THIS PAGE PLEASE CONTACT cancernewsnetwork (at) live.com.
We will do our best to accommodate your request.



COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy